Abstract:HomeStrokeVol. 53, No. 9Treatment and 1-Year Prognosis of Ischemic Stroke in China in 2018: A Hospital-Based Study From Bigdata Observatory Platform for Stroke of China Free AccessResearch ArticlePDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissionsDownload Articles + Supplements ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toSupplemental MaterialFree AccessResearch ArticlePDF/EPUBTreatment and 1-Year Prognosis of Ischemic Stroke in China in 2018: A Hospital-Based Study From Bigdata Observatory Platform for Stroke of China Wen-Jun Tu, Feng Yan, Bao-Hua Chao, Lei Cao and Longde Wang Wen-Jun TuWen-Jun Tu https://orcid.org/0000-0002-1703-1802 Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China (W.-J.T.). The General Office of Stroke Prevention Project Committee, National Health Commission of the People's Republic of China, Beijing, China (W.-J.T., F.Y., B.-H.C., L.C., L.W.). , Feng YanFeng Yan The General Office of Stroke Prevention Project Committee, National Health Commission of the People's Republic of China, Beijing, China (W.-J.T., F.Y., B.-H.C., L.C., L.W.). , Bao-Hua ChaoBao-Hua Chao The General Office of Stroke Prevention Project Committee, National Health Commission of the People's Republic of China, Beijing, China (W.-J.T., F.Y., B.-H.C., L.C., L.W.). , Lei CaoLei Cao The General Office of Stroke Prevention Project Committee, National Health Commission of the People's Republic of China, Beijing, China (W.-J.T., F.Y., B.-H.C., L.C., L.W.). and Longde WangLongde Wang Correspondence to: Longde Wang, MD, No. 118, Guang'anmen Inner St, Beijing, 100053, China. Email E-mail Address: [email protected] https://orcid.org/0000-0002-2156-7909 The General Office of Stroke Prevention Project Committee, National Health Commission of the People's Republic of China, Beijing, China (W.-J.T., F.Y., B.-H.C., L.C., L.W.). Originally published22 Jul 2022https://doi.org/10.1161/STROKEAHA.121.038260Stroke. 2022;53:e415–e417Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: July 22, 2022: Ahead of Print Stroke is associated with the highest disability-adjusted life years lost in China, with over 2 million new cases annually.1 In addition, deaths caused by stroke are rising rapidly in China, more so than in other countries.2 However, there are few studies that have provided nationwide data on stroke treatment and outcomes in China. This study aims to assess the treatment and 1-year prognosis of ischemic stroke in China in 2018.MethodsIn December 2017, we randomly selected 100 hospitals (at least one in each province) from the Bigdata Observatory Platform for Stroke of China3 (Supplemental Material I). Hospitals participating in the Bigdata Observatory Platform for Stroke of China included mandatory and voluntary. From January to December 2018, all patients with first-ever ischemic stroke and symptom onset within 14 days were included. The Ethics Committee of Brain Hospital of Hunan Province (No. Z2017006) and Peking Union Medical College Hospital (JS-2289) approved this study, and written informed consent was obtained. A complete description of the information collected has been reported previously.3 Telephone follow-up was conducted after 1 year after baseline. Case fatality, disability, and recurrence rates were assessed, and a percentage and 95% CIs were presented. Multivariable logistic regression was used to examine the association of variables with the odds of outcomes (Supplemental Material II).ResultsIn total, 74 904 ischemic strokes from 83 hospitals from 30 provinces (median [interquartile range] age, 68 [58–74] years; 61.27% male) were recruited. Two thousand six hundred eighty-nine (3.59% [95% CI, 3.46%–3.72%]) patients received thrombolytic therapy and 820 (1.09%) patients received thrombectomy treatment. At discharge, the fatality rate was 1.23% (95% CI, 1.15%–1.31%). The discharge against medical advice rate was 5.34% (95% CI, 5.18%–5.50%; Table S1). In-hospital fatality rate was higher in those old patients (≥60 years) than in those young patients (<60 years). There were regional differences in the in-hospital fatality rate (Figure).Download figureDownload PowerPointFigure. Subgroup analysis in the discharge and 1-y follow-up (those results were unweighted data as % [95% CI]). Disability was defined as an modified Rankin Scale (mRS) of 3 to 5 points. bModel covariates were age, sex, history of stroke, hypertension, diabetes, hyperlipidemia, atrial fibrillation, coronary artery disease, coagulopathy, heart failure, peripheral arterial disease, carotid stenosis, hyperhomocysteinemia, stroke severity, hospital grade, region, stroke unit, and teaching hospital status. Sex: female vs male; age: ≥60 vs <60. cThe highest-level region vs lowest region; in-hospital fatality: Northwest China (NW) vs CC, in-hospital fatality/discharge against medical advice (DAMA): SW vs NC; 1-year fatality: SC vs North China (NC), 1-year recurrence: Northeast China (NE) vs SC, 1-year disability: SC vs NC. d,e,fRepresent the P for each region compared with North China (NC), which we have selected as the reference region; dFor P<0.05, efor P<0.01, and ffor P<0.001. CC indicates Central China; EC, East China; N, number of patients; n, number of hospitals; and SW, Southwest China.During the follow-up period, the fatality rate was 6.81% (95% CI, 6.62%–7.00%; Table S2. The fatality rate was higher in those old patients than in those young patients. In addition, men patients had a lower fatality rate than women. The fatality rate varied significantly between different regions (Figure). The case recurrence rate was 7.74% (95% CI, 7.54%–7.94%), and the disability rate of stroke survivors was 15.42% (95% CI, 15.14%–15.70%; Table S2). Stroke recurrence rate and disability rate of stroke survivors were higher in those old patients than in those young patients and varied greatly between different regions (Figure).DiscussionThis nationwide study shows the rate of thrombolytic therapy and 1-year outcomes in patients with ischemic stroke. Another study showed that the in-hospital death/discharge against the medical advice rate was 5.3% (5.0%–5.5%) for ischemic stroke.4 The China Kadoorie Biobank showed that among those who survived 28 days after the first stroke, the 1-year case fatality and recurrence rates were 4% and 17%.5 The prognosis of ischemic stroke in China is better than in high-income countries despite the low thrombolytic rates.1 Furthermore, the fatality and disability rates trend are low in north China and high in the south, while the recurrence rate shows the opposite direction. Hospitals with a low sample size and low follow-up rate were excluded. This may cause selection bias as patients in these excluded hospitals might have less access to treatment and worse outcomes. This study provides a scientific basis for the Chinese population by establishing a database of stroke patients in China, studying the rules and trends of disease treatment and prognosis.Article InformationSources of FundingThis study was supported by the National Major Public Health Service Projects.Supplemental MaterialBigdata Observatory Platform for Stroke of ChinaSupplemental Materials and MethodsTables S1–S2FootnotesSupplemental Material is available at https://www.ahajournals.org/doi/suppl/10.1161/STROKEAHA.121.038260.Correspondence to: Longde Wang, MD, No. 118, Guang'anmen Inner St, Beijing, 100053, China. Email wangld@nhfpc.gov.cnReferences1. Wu S, Wu B, Liu M, Chen Z, Wang W, Anderson CS, Sandercock P, Wang Y, Huang Y, Cui L, et al; China Stroke Study Collaboration. Stroke in China: advances and challenges in epidemiology, prevention, and management.Lancet Neurol. 2019; 18:394–405. doi: 10.1016/S1474-4422(18)30500-3CrossrefMedlineGoogle Scholar2. Li Z, Jiang Y, Li H, Xian Y, Wang Y. China's response to the rising stroke burden.BMJ. 2019; 364:l879. doi: 10.1136/bmj.l879CrossrefMedlineGoogle Scholar3. Shen Y, Chao BH, Cao L, Tu WJ, Wang LD. Stroke center care and outcome: results from the CSPPC stroke program.Transl Stroke Res. 2020; 11:377–386. doi: 10.1007/s12975-019-00727-6CrossrefGoogle Scholar4. Tu WJ, Chao BH, Ma L, Yan F, Cao L, Qiu H, Ji XM, Wang LD. Case-fatality, disability and recurrence rates after first-ever stroke: a study from bigdata observatory platform for stroke of China.Brain Res Bull. 2021; 175:130–135. doi: 10.1016/j.brainresbull.2021.07.020CrossrefGoogle Scholar5. Chen Y, Wright N, Guo Y, Turnbull I, Kartsonaki C, Yang L, Bian Z, Pei P, Pan D, Zhang Y, et al. Mortality and recurrent vascular events after first incident stroke: a 9-year community-based study of 0· 5 million Chinese adults.Lancet Glob Health. 2020; 8:e580–e590. doi: 10.1016/S2214-109X(20)30069-3CrossrefMedlineGoogle Scholar eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetailsCited By Tu W and Xu Y (2023) A response to a letter to the editor TR-D-22-00887, Thrombosis Research, 10.1016/j.thromres.2023.01.009, 223, (34-35), Online publication date: 1-Mar-2023. Tu W, Xu Y, Chen H, Li J and Du J (2023) Impact of the COVID-19 pandemic lockdown on hospitalizations for cerebrovascular disease and related in-hospital mortality in China: A nationwide observational study, Archives of Gerontology and Geriatrics, 10.1016/j.archger.2022.104832, 104, (104832), Online publication date: 1-Jan-2023. Tu W, Xu Y, Liu Y, Du J and Zhao J (2022) Endovascular thrombectomy or bridging therapy in minor ischemic stroke with large vessel occlusion, Thrombosis Research, 10.1016/j.thromres.2022.09.020, 219, (150-154), Online publication date: 1-Nov-2022. September 2022Vol 53, Issue 9 Advertisement Article InformationMetrics © 2022 American Heart Association, Inc.https://doi.org/10.1161/STROKEAHA.121.038260PMID: 35866427 Originally publishedJuly 22, 2022 Keywordsischemic strokeprognosisdisability-adjusted life yearshospitaltreatment outcomePDF download Advertisement SubjectsIschemic Stroke

Abstract:HomeStrokeVol. 37, No. 4Has Stroke Shifted From Hemorrhagic to Ischemic in China? Free AccessLetterPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessLetterPDF/EPUBHas Stroke Shifted From Hemorrhagic to Ischemic in China? Gelin Xu, MD and Xinfeng Liu, MD Gelin XuGelin Xu Department of Neurology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu Province, China and Xinfeng LiuXinfeng Liu Department of Neurology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu Province, China Originally published1 Apr 2006https://doi.org/10.1161/01.STR.0000210186.07530.69Stroke. 2006;37:941–942To the Editor:In China, which has the largest population and greatest number of stroke victims in the world, data concerning stroke epidemiology are very limited. Guidelines of stroke prevention and management designed for Chinese were tailored, to a considerable degree, according to the epidemiological, etiological and clinical profiles mirrored from western populations. The higher morbidity and mortality of stroke in Chinese further bulks the need of nationwide epidemiological data for establishing population specialized strategies for stoke prevention and management.We read with great interest the study by Jiang et al concerning the stroke incidence and trends in 3 large cities in China.1 It was shown that incidence of intracranial hemorrhage (ICH) decreased significantly at an annual rate of 12.0% in Beijing, 4.4% in Shanghai, and 7.7% in Changsha; at the time, incidence of ischemic stroke (IS) increased in Beijing (5.0% per year) and Shanghai (7.7%) during the 1990s. As reasoning this opposite trends of ischemic and hemorrhagic stroke, the authors wrote:These (lifestyle) changes may have resulted in increased prevalence of obesity, hypertension, diabetes, and hypercholesterolemia in Chinese populations and may also help explain the increasing trend of IS as observed in this study. Uncontrolled hypertension and high prevalence of smoking might partially explain the hemorrhagic stroke predominance among Chinese in the past, and the increasing awareness of hypertension control and decrease in cigarette smoking may have contributed to its decrease in the past decade.These explanations are ridiculous because it means hypertension and other risk factors were increasing when interpreting the trends of IS, while these risk factors were controlled and decreasing when interpreting the trends of ICH. Furthermore, well-designed large epidemiological studies indicated prevalence of cigarette smoking was increasing in the 1980s and 1990s,2 and percentage of smokers contemplating quitting was low in China.3 The incidence of hypertension and diabetes mellitus were also increased throughout the 1990s in China.4,5 Under these circumstances, it is rather arbitrary to interpret the 12% annual decrease of ICH incidence detected in this study as a result of some underlying changes of risk factors in Chinese population.On the other hand, the results that IS increased and ICH decreased during 1990s can be more reasonably explained by the misclassification of stroke patients, especially during the early days of this study when CT and MRI scans were less available. In the absence of neuroimaging results, IS may be misclassified as ICH and vice versa. This study did not provide substantive classification criteria applied at time of stroke onset. The Atherosclerosis Risk in Communities (ARIC) criteria for stroke diagnosis and classification used in this study were published many years after the initiation of the study.6 In the ARIC study, the rate of cases with CT scan is higher (84%), and stroke patients were possibly classified as definite cerebral infarction or definite ICH only when autopsy results or CT/MRI scans were available. For stroke patients without neuroimaging or autopsy results, a probable classification was made. When a stroke case was equivocal, it was classified following the hierarchy of ICH, subarachnoid hemorrhage, embolic brain infarction and thrombotic brain infarction. This indicates that equivocal cases were more probably classified as ICH than as IS. This arbitrary allocation will undoubtedly increase the possibility of IS being misclassified as ICH especially in patients without CT or MRI scans. Many patients who had been diagnosed in the early days of this study (eg, >50% of the patients diagnosed in 1991 in Shanghai) did not have a CT or MRI scan. For these patients ICH may be overdiagnosed.In a large multicenter collaborative study which included Beijing and Shanghai as this study did, Zhang and colleagues showed proportion of clinically diagnosed7 ICH in total stroke was increased gradually during the early years of the 1990s (which are contrary to the results of this study), a time when clinical application of CT and MRI was booming in mainland China. But when ratio of patients with CT scan reached a satisfying 85% after 1996, proportion of ICH kept considerably equivalent over years. These results indicate that inconsistency in stroke classification related to increasing use of CT/MRI scan may be a prominent obstruction in evaluating the temporal trends of stokes components.This article provides valuable information of stroke incidence in urban China. However, because of significant design flaw and lack of valid criteria for stroke classification, the conclusion that the decreased ICH and increased IS was caused by underlying changes of risk factors in Chinese populations is misleading.1 Jiang B, Wang WZ, Chen H, Hong Z, Yang QD, Wu SP, Du XL, Bao QJ. Incidence and trends of stroke and its subtypes in China: results from three large cities. Stroke. 2006; 37: 63–68.LinkGoogle Scholar2 Yang G, Fan L, Tan J, Qi G, Zhang Y, Samet JM, Taylor CE, Becker K, Xu J. Smoking in China: findings of the 1996 National Prevalence Survey. JAMA. 1999; 282: 1247–1253.CrossrefMedlineGoogle Scholar3 Yang G, Ma J, Chen A, Zhang Y, Samet JM, Taylor CE, Becker K. Smoking cessation in China: findings from the 1996 national prevalence survey. Tob Control. 2001; 10: 170–174.CrossrefMedlineGoogle Scholar4 Ueshima H, Zhang XH, Choudhury SR. Epidemiology of hypertension in China and Japan. J Hum Hypertens. 2000; 14: 765–769.CrossrefMedlineGoogle Scholar5 Chan JC, Ng MC, Critchley JA, Lee SC, Cockram CS. Diabetes mellitus–a special medical challenge from a Chinese perspective. Diabetes Res Clin Pract. 2001; 54: S19–S27.CrossrefMedlineGoogle Scholar6 Rosamond WD, Folsom AR, Chambless LE, Wang CH, McGovern PG, Howard G, Copper LS, Shahar E. Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke. 1999; 30: 736–743.CrossrefMedlineGoogle Scholar7 Zhang LF, Yang J, Hong Z, Yuan GG, Zhou BF, Zhao LC, Huang YN, Chen J, Wu YF; Collaborative Group of China Multicenter Study of Cardiovascular Epidemiology. Proportion of different subtypes of stroke in China. Stroke. 2003; 34: 2091–2096.LinkGoogle ScholarstrokeahaStrokeStrokeStroke0039-24991524-4628Lippincott Williams & WilkinsJiang Bin, , MD, MPH and Wang Wen-zhi, , MD01042006Response:We thank Drs Xu and Liu for their interest in our recent publication on the stroke trends in 3 cities of China,1 and we reply to clarify their questions about our stroke diagnostic criteria and classification in our study and provide some further information regarding our study that we could not include in the original report because of the space limitation. However, we believe what we observed in our study was real, and our inference of the shift from hemorrhage to ischemic stroke pattern in China was correctly drawn.The criteria for stroke diagnosis and classification were similar to those used in the Atherosclerosis Risk in Communities (ARIC) Study, both of which were adapted from published criteria from the National Survey of Stroke.2 Minor modifications were made to facilitate the field data collection in China. The major differences between the criteria used in these 2 studies,1,3 other than languages, included: (1) "unilateral numbness of 2 or more body parts" was regarded as a major symptom in our study but a minor symptom in the ARIC study; (2) in the ARIC Study, a hierarchical case definition was used for the rare situation where the cases met criteria for 2 different diagnostic categories. In our study, we defined such cases as "undetermined", even for cases with CT/MRI information. Conversely, cases only with neuroimaging data without clinical symptoms and signs were excluded. As in many other epidemiological studies, misclassifications were expected, but diagnostic errors should be few.We shared Dr Xu et al's concern that >10% of the stroke subtypes were classified based on clinical examinations. This was true for the first several years of follow-up. CT/MRI technologies have become readily available in Beijing and Shanghai (>90%) since mid-1990s. Further, the high hospitalization rate and high quality medical service in these large cities should have to some extent alleviated such a concern. As noted by Dr Xu et al, ICH in total stroke gradually increased in the study by Zhang et al in early 1990s.4 However, CT use was slightly lower in that study compared to ours, and the increasing trend of ICH in total stroke stopped since 1996 when CT was used in 85% of their case diagnoses.1,4We believe that the trend we observed in our study reflects the changes of stroke incidence and composition in our study populations. Further, our observation was consistent with the findings from the MONICA study in Beijing during 1984 to 1999.5 However, our potential explanations are speculative and we have made it clear in our discussion. More studies are needed to confirm our findings in both urban and rural Chinese populations and to find out the reasons underlying these changes. Previous Back to top Next FiguresReferencesRelatedDetails April 2006Vol 37, Issue 4 Advertisement Article InformationMetrics https://doi.org/10.1161/01.STR.0000210186.07530.69PMID: 16567662 Originally publishedApril 1, 2006 PDF download Advertisement

Serum Irisin Levels are Inversely Correlated with Acute Ischaemic Stroke Incidence: Implications for Early Diagnosis in Southern China

Low Serum Superoxide Dismutase is Associated with a High Risk of Cognitive Impairment after Mild Acute Ischemic Stroke

Treatment and 1-Year Prognosis of Ischemic Stroke in China in 2018: A Hospital-Based Study from Bigdata Observatory Platform for Stroke of China

Serum IL-31 is related to the severity and 3-month prognosis of patients with Intracerebral hemorrhage

Significant Delay and Decreased Chance of Treatment for Acute Ischemic Stroke Patients on Remote Outer Islets of China Compared with the Main Island: the PUTUO Study.

Serum Irisin Predicts Mortality Risk in Acute Heart Failure Patients

The Association of the Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, Lymphocyte-to-Monocyte Ratio and Systemic Inflammation Response Index with Short-Term Functional Outcome in Patients with Acute Ischemic Stroke

Elevated Serum HMGB1 Levels and Their Association with Recurrence of Acute Ischaemic Stroke

Increased serum interleukin-34 levels as a novel diagnostic and prognostic biomarker in patients with acute ischemic stroke

2 Stroke July 2015 China does not emphasize or promote the importance of

Association of Uric Acid, High-Sensitivity C-Reactive Protein, and 90-Day Risk of Poor Function Outcome in Patients with Ischemic Stroke or Transient Ischemic Attacks

Characteristics and clinical significance of serum renalase in patients with acute ischemic stroke

Correlation of Peripheral Blood Inflammatory Indicators to Prognosis After Intravenous Thrombolysis in Acute Ischemic Stroke: A Retrospective Study

Risk Factors of Incident Total Stroke and Ischemic Stroke in China

Correlation analysis of inflammatory markers with the short-term prognosis of acute ischaemic stroke

Healthcare-Seeking Delays in Acute Ischemic Stroke Patients: The Influence of Gender, Immigrant Status, and Educational Background

Increased interleukin-18 level contributes to the development and severity of ischemic stroke

Association of high serum β2-microglobulin levels with poor functional outcomes in patients with acute ischemic stroke: A cohort study

Has Stroke Shifted from Hemorrhagic to Ischemic in China?

Overexpression of sirtuin 2 and its association with prognosis in acute ischemic stroke patients